I am/have/had
I am looking for
Advanced Filters
Found 245 clinical trials
Preliminary Antitumor Activity Safety and Tolerability of Tislelizumab in Combination With Lenvatinib for Hepatocellular Carcinoma
The primary objective of this study is to assess the preliminary antitumor activity as indicated by overall response rate (ORR) of tislelizumab in combination with lenvatinib in participants with unresectable locally advanced or metastatic hepatocellular carcinoma (HCC).
hepatocellular carcinoma
liver cancer
cholangiocarcinoma
metastatic hepatocellular carcinoma
carcinoma
- 0 views
- 19 Feb, 2024